PDCD1 and opsoclonus-myoclonus syndrome: In conclusion, our study demonstrated mRNA expression of PD‐L1, PD‐1 and CTLA‐4 by both neoplastic and immune cells in canine OMs, supporting their role in immunosuppression and in promoting tumour progression.